Research Into the Treatment of Anemia for Critically Ill Patients Admitted to Intensive Care Units (ICU)
Phase 3
Completed
- Conditions
- Anemia
- First Posted Date
- 2004-09-21
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 1460
- Registration Number
- NCT00091910
A Study of Docetaxel Monotherapy or DOXIL and Docetaxel in Patients With Advanced Breast Cancer
- First Posted Date
- 2004-09-13
- Last Posted Date
- 2014-04-21
- Target Recruit Count
- 751
- Registration Number
- NCT00091442
Investigate Risperidone for the Treatment of Schizophrenia in Adolescents
Phase 3
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2004-07-21
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 160
- Registration Number
- NCT00088075
Effectiveness and Safety Study of Pentosan Polysulfate Sodium for the Treatment of Interstitial Cystitis
Phase 4
Terminated
- Conditions
- Interstitial Cystitis
- Interventions
- Drug: PlaceboDrug: Pentosan polysulfate sodium 100 mg
- First Posted Date
- 2004-07-09
- Last Posted Date
- 2014-04-21
- Target Recruit Count
- 369
- Registration Number
- NCT00086684
A Study of Effectiveness and Safety of Paliperidone Extended-release (ER) Tablets in the Prevention of Recurrence in Adult Patients With Schizophrenia.
Phase 3
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2004-07-01
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 111
- Registration Number
- NCT00086320
Study Comparing Risperidone vs Placebo as add-on Therapy in Patients With Generalized Anxiety Disorder Who Are Sub-optimally Responding to Standard Therapy.
Phase 3
Completed
- Conditions
- Anxiety Disorders
- First Posted Date
- 2004-06-28
- Last Posted Date
- 2012-07-23
- Target Recruit Count
- 301
- Registration Number
- NCT00086112
Safety Study With Paliperidone ER Extended-Release (ER) Tablets in Geriatric Patients With Schizophrenia
Phase 3
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2004-06-16
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 114
- Registration Number
- NCT00085748
Trial Evaluating Three Fixed Doses of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia
Phase 3
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2004-05-28
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 619
- Registration Number
- NCT00083668
Treatment of Anemia in Patients With Cancer Who Are Not Currently Receiving Chemotherapy or Radiotherapy
Phase 3
Terminated
- Conditions
- Anemia
- Locations
- 🇺🇸
Southern Illinois Hematology, Centralia, Illinois, United States
🇺🇸Spalding Oncology Services, Griffin, Georgia, United States
🇺🇸NorthEast Urology Research, Concord, North Carolina, United States
Treatment of Anemic Patients With Cancer Who Are Not Receiving Chemotherapy or Radiotherapy
Phase 3
Terminated
- Conditions
- AnemiaCancer
- Locations
- 🇺🇸
Madigan Army Medical Center Urology Services, Tacoma, Washington, United States
🇺🇸Hanover Medical Specialists, PA, Wilmington, North Carolina, United States
🇺🇸Advanced Urology Medical Center, Anaheim, California, United States
© Copyright 2025. All Rights Reserved by MedPath